[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334806-105":59,"doc-detail-334806-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advancements-in-nsclc-from-pathophysiological-insights-to-targeted-treatments-review-and-targeted-therapies","Advancements in NSCLC - From Pathophysiological Insights to Targeted Treatments - review and targeted therapies","","With the global incidence of non-small cell lung cancer (NSCLC) increasing, innovative treatment strategies are essential. This review highlights precision medicine as a key approach to improve NSCLC care by integrating genomic and epigenomic insights. It examines major gene mutations and traces how targeted therapies evolved, assessing their effects on survival and quality of life. Limited availability of targeted options despite many identified mutations motivates continued research.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advancements-in-nsclc-from-pathophysiological-insights-to-targeted-treatments-review-and-targeted-therapies/334806/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advancements-in-nsclc-from-pathophysiological-insights-to-targeted-treatments-review-and-targeted-therapies/334806.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is precision medicine important for NSCLC management?","Question",{"text":112,"@type":113},"Precision medicine enables treatment choices grounded in genomic and epigenomic insights, improving outcomes. The review emphasizes integrating molecular information to guide therapy for NSCLC patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the review focus on regarding gene mutations and targeted therapies?",{"text":117,"@type":113},"The review highlights identification of key gene mutations and explains how targeted therapies evolved and their impact on survival and quality of life. It also notes that targeted treatments are available only for a limited subset despite many known mutations.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the main limitations of current NSCLC treatments mentioned?",{"text":121,"@type":113},"Traditional approaches such as surgery, radiotherapy, and chemotherapy can show limited efficacy in advanced disease. The review also points to recurrence or metastasis after initial treatment and multiple adverse side effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334806,1790195725,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Advancements in NSCLC  \nFrom Pathophysiological Insights to Targeted Treatments  \nJianan Xu, PhD,* Lin Tian, MSc,† Wenlong Qi, MSc,† Qingguo Lv, MSc,† and  \nTan Wang, PhD†  \nAbstract: With the global incidence of non-small cell lung cancer (NSCLC) on the rise, the development of innovative treatment strategies is increasingly vital. This review underscores the pivotal role of precision medicine in transforming NSCLC management, particularly through the integration of genomic and epigenomic insights to enhance treatment outcomes for patients. We focus on the identiﬁcation of key gene mutations and examine the evolution and impact of targeted therapies. These therapies have shown encouraging results in improving survival rates and quality of life. Despite numerous gene mutations being identiﬁed in association with NSCLC, targeted treatments are available for only a select few. This paper offers an exhaustive analysis of the pathogenesis of NSCLC and reviews the latest advancements in targeted therapeutic approaches. It emphasizes the ongoing necessity for research and development in this domain. In addition, we discuss the current challenges faced in the clinical application of these therapies and the potential directions for future research, including the identiﬁcation of novel targets and the development of new treatment modalities.  \nKey Words: NSCLC, targeted therapy, molecular mechanisms, targeted drugs  \n(Am J Clin Oncol 2024;47:291–303)  \nLung cancer persistently ranks atop global oncological  \nmortalities.1 The therapeutic approach for this malignancy is contingent upon a myriad of variables, encompassing the patient’s histopathologic classiﬁcation, tumor gradation, molecular hallmarks, and a holistic evaluation of the patient’s overall well-being.2 Among the delineated lung cancer subtypes, non-small cell lung cancer (NSCLC) is preeminent, constituting ~85% of cases.3 Owing to its aggressive phenotype, NSCLC exacts a profound impact on patients, their familial networks, and the broader societal milieu.  \nPertaining to the pathogenesis of NSCLC, its exact etiology continues to elicit scholarly discourse. Nonetheless, a wealth of evidence accentuates the cardinal inﬂuence of multigenic anomalies and the sophisticated dynamics within signaling cascades.4–6 Remarkably, ~60% of patients with lung adenocarcinoma possess identiﬁable driver gene aberrations, inclusive of EGFR, ALK, and  \nFrom the *College of Traditional Chinese Medicine, Changchun University of Chinese Medicine; and †Pulmonology Department, The Afﬁliated Hospital to Changchun University of Chinese Medicine, Changchun, P.R. China.  \nThe authors declare no conﬂicts of interest.  \nCorrespondence: Tan Wang, PhD, No. 1478 Gongnong Road, Chaoyang District, Changchun 130000, [P.R. China. E-mail: wangtan0215@163.com](P.R. China. E-mail: wangtan0215@163.com).  \nCopyright © 2024 The Author(s) . Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in anyway or used commercially without permission from the journal.  \nISSN: 0277-3732/24/4706-0291  \nDOI: 10.1097/COC.0000000000001088  \nROS1.7 Such mutations instigate modulations in receptors and protein kinases, potentially precipitating disruptions in interconnected signaling pathways, leading inexorably to rampant tumor cell growth, inﬁltration, and persistence.8 Moreover, this malignant expansion undermines the balance of angiogenesis, compelling neoplastic cells to orchestrate novel vascular networks, thereby facilitating their accelerated expansion.9  \nFor decades, surgical modalities, radiotherapy, and chemotherapy have been the mainstay defenses against NSCLC.10 However, their therapeutic efﬁcacy is often limited, especially in cases presenting advanced disease stages.11 ","cbCaipLkYycJSyot","https://ap.wps.com/l/cbCaipLkYycJSyot","pdf",371176,13,"English","# Abstract\n# Introduction\n# Pathogenesis of NSCLC\n## Driver Gene Mutation\n## EGFR\n# Targeted Treatments and Clinical Challenges\n# Future Research Directions","[{\"question\":\"Why is precision medicine important for NSCLC management?\",\"answer\":\"Precision medicine enables treatment choices grounded in genomic and epigenomic insights, improving outcomes. The review emphasizes integrating molecular information to guide therapy for NSCLC patients.\"},{\"question\":\"What does the review focus on regarding gene mutations and targeted therapies?\",\"answer\":\"The review highlights identification of key gene mutations and explains how targeted therapies evolved and their impact on survival and quality of life. It also notes that targeted treatments are available only for a limited subset despite many known mutations.\"},{\"question\":\"What are the main limitations of current NSCLC treatments mentioned?\",\"answer\":\"Traditional approaches such as surgery, radiotherapy, and chemotherapy can show limited efficacy in advanced disease. The review also points to recurrence or metastasis after initial treatment and multiple adverse side effects.\"}]","Advancements in NSCLC - From Pathophysiological Insights to Targeted Treatments - review and targeted therapies | PDF",1790008418,33]